Season 2 of Rheum Advisor on Air, the official podcast of Rheumatology Advisor, is set to kick off with the ACR Convergence 2021 series, followed by expert perspectives on emerging topics in rheumatology.
At this year’s ACR Convergence Great Debate, Michelle Petri, MD, MPH, and Brad Rovin, MD, discuss their preferred choice of add-on drug – belimumab or voclosporin – to standard lupus nephritis therapy.
The American College of Rheumatology (ACR) Convergence 2021, being held virtually between November 3 and 10, will include new sessions and presentations on data from rheumatology research and clinical practice.
The American Academy of Pediatrics (AAP) released a policy statement and an accompanying clinical report on identifying and addressing the effects of trauma and stress on children, families, and their health care providers.
The American College of Rheumatology developed updated guidelines for the pharmacologic management of patients with rheumatoid arthritis.
Allan Gibofsky, MD, and Michael Schweitz, MD, discuss guidance for immunocompromised patients in light of the recent news surrounding the Johnson & Johnson/Janssen COVID-19 vaccine.
A collaboration between clinicians, researchers, and authors in rheumatology, ophthalmology, dermatology, and pulmonology for National Autoimmune Disease Awareness Month in March.
In this interview, Laurent Arnaud, MD, PhD, and Laura Boekel, MD, each discuss findings from their studies on the perspectives and concerns of patients with autoimmune diseases regarding COVID-19 vaccination.
